Interestingly, the correlation between poor prognosis and EB1 overexpression in tumors applies to other cancers, such as esophageal cell carcinoma, breast cancer, gastric adenocarcinoma, colorectal cancer, and glioblastoma [6–10]. Here, MAPRE1 is linked to cancer.